[{"type": "title", "data": "PAL Lidocaine for Neuropathic Pain"}, {"type": "category", "data": "Status"}, {"type": "note", "data": "Restricted to Palliative Care / Anaesthesia Service", "value": ""}, {"type": "category", "data": "Patient Care"}, {"type": "order", "data": "Weight", "value": "checked"}, {"type": "sentence", "data": "Within the last 7 days"}, {"type": "order", "data": "Vital Signs", "value": "checked"}, {"type": "sentence", "data": "once, baseline"}, {"type": "order", "data": "Vital Signs", "value": "checked"}, {"type": "sentence", "data": "q15min, when administering Lidocaine IV intermittent"}, {"type": "order", "data": "Vital Signs", "value": "checked"}, {"type": "sentence", "data": "q8h when administering continuous Lidocaine IV/SC infusion"}, {"type": "order", "data": "Communication Order", "value": "checked"}, {"type": "sentence", "data": "T;N, See order comment"}, {"type": "order", "data": "Notify Treating Provider", "value": "checked"}, {"type": "sentence", "data": "If signs and symptoms of toxicity during infusion develop and stop infusion"}, {"type": "category", "data": "Continuous Infusions"}, {"type": "order", "data": "sodium chloride 0.9% (NS) continuous infusion", "value": ""}, {"type": "sentence", "data": "order rate: 30 mL/h, IV, drug form: bag"}, {"type": "category", "data": "Medications"}, {"type": "note", "data": "Lidocaine Intermittent Infusion", "value": ""}, {"type": "order", "data": "lidocaine bolus", "value": ""}, {"type": "sentence", "data": "5 mg/kg, IV, once, drug form: bag"}, {"type": "sentence", "data": "900 mg, IV, once, drug form: bag"}, {"type": "sentence", "data": "10 mg/kg, IV, once, drug form: bag"}, {"type": "sentence", "data": "900 mg, IV, once, drug form: bag"}, {"type": "note", "data": "Maintenance doses should be reduced if severe heart failure or liver disease", "value": ""}, {"type": "note", "data": "Maintenance IV Continuous Infusions", "value": ""}, {"type": "order", "data": "lidocaine titratable infusion (4 mg/mL) in D5W standard", "value": ""}, {"type": "sentence", "data": "titrate, IV, 0.5 mg/kg/h minimum rate, 3 mg/kg/h maximum rate"}, {"type": "sentence", "data": "1 g"}, {"type": "order", "data": "lidocaine bolus", "value": ""}, {"type": "sentence", "data": "2 mg/kg, IV, once, drug form: bag"}, {"type": "note", "data": "Maintenance Subcutaneous Continuous Infusions", "value": ""}, {"type": "order", "data": "lidocaine subcutaneous titratable infusion (20 mg/mL) undiluted standard", "value": ""}, {"type": "sentence", "data": "titrate, subcutaneous, 0.5 mg/kg/h minimum rate, 3 mg/kg/h maximum rate"}, {"type": "sentence", "data": "2 g"}, {"type": "order", "data": "lidocaine bolus", "value": ""}, {"type": "sentence", "data": "2 mg/kg, subcutaneous, once, drug form: bag"}, {"type": "note", "data": "Treatment of Adverse Effects", "value": ""}, {"type": "order", "data": "capTOPRil", "value": ""}, {"type": "sentence", "data": "12.5 mg, PO, q30min, PRN hypertension, order duration: 2 doses or times, drug form: tab"}, {"type": "order", "data": "LORazepam PRN range dose", "value": ""}, {"type": "sentence", "data": "dose range: 1 to 2 mg, IV, q10min, PRN seizure activity, drug form: inj"}, {"type": "order", "data": "LORazepam PRN range dose", "value": ""}, {"type": "sentence", "data": "dose range: 1 to 2 mg, subcutaneous, q10min, PRN seizure activity, drug form: inj"}, {"type": "category", "data": "Laboratory"}, {"type": "order", "data": "Electrolytes Urea Creatinine Panel", "value": "checked"}, {"type": "sentence", "data": "Blood, Routine, Collection: T;N, once"}, {"type": "order", "data": "Hepatic Panel (Bilirubin, ALP, Alb, ALT, GGT)", "value": "checked"}, {"type": "sentence", "data": "Blood, Routine, Collection: T;N, once"}, {"type": "order", "data": "Other Trough Draw Instructions", "value": ""}, {"type": "sentence", "data": "once, Draw Lidocaine level 8 to 12 hours after initiation or increase in infusion rate of continuous Lidocaine IV infusion"}, {"type": "order", "data": "Other Peak Draw Instructions", "value": ""}, {"type": "sentence", "data": "once, Draw Lidocaine level 24 to 72 hours after initiation or increase in infusion rate of continuous Lidocaine SC infusion"}, {"type": "category", "data": "Diagnostic Tests"}, {"type": "order", "data": "Electrocardiogram 12 Lead", "value": ""}, {"type": "sentence", "data": "Routine, baseline"}, {"type": "note", "data": "If clinically indicated, repeat ECG and labwork during infusion", "value": ""}, {"type": "category", "data": "Communication Orders"}, {"type": "order", "data": "Communication Order", "value": "checked"}, {"type": "sentence", "data": "Stop lidocaine and call MD if HR less than 45 BPM OR SBP less than 100 mmHg OR SBP greater than 180 mmHg or other side-effect occurs, particularly metallic taste, perioral numbness or tingling."}]
